Zhang Qing, Sui AiMin, Su Min, Ju MingLiang, Wei YanYan, Tang XiaoChen, Xu LiHua, Cui HuiRu, Tang YingYing, Yi ZhengHui, Liu HaiChun, Gao Jin, Wang JiJun, Zhang TianHong
Shanghai Mental Health Center, Shanghai Jiaotong University School of Medicine, Shanghai Engineering Research Center of Intelligent Psychological Evaluation and Intervention, Shanghai Key Laboratory of Psychotic Disorders, Shanghai, China.
Department of Psychiatry, Taizhou Second People's Hospital, Zhejiang, China.
Front Psychiatry. 2025 Aug 4;16:1642291. doi: 10.3389/fpsyt.2025.1642291. eCollection 2025.
INTRODUCTION: Cognitive impairment is a core feature of first-episode schizophrenia (FES), yet the influence of biological sex on its manifestation remains under characterized. Existing evidence suggests sex differences in cognitive profiles among chronic schizophrenia patients, but whether these patterns emerge in drug-naïve FES patients-and how they relate to clinical symptoms-requires clarification. METHODS: We recruited 382 drug-naïve FES patients and 522 healthy controls (HCs) matched for age and education. Cognitive function was assessed using the MATRICS Consensus Cognitive Battery (MCCB). Clinical symptoms were evaluated via the Positive and Negative Syndrome Scale (PANSS). RESULTS: FES patients demonstrated global cognitive deficits compared to HCs. When stratified by diagnostic group (FES and HC), males outperformed females in planning and problem-solving, as measured by the Neuropsychological Assessment Battery Mazes subtest ( < 0.001), whereas females showed superior performance in visuospatial memory, as assessed by the Brief Visuospatial Memory Test-Revised ( < 0.001) in both groups. When stratified by gender, FES patients exhibited similar patterns of impairment severity relative to their gender-matched HCs: both male and female FES patients showed the most pronounced deficits in processing speed (BACS) and sustained attention (CPT), with effect sizes of 1.64 and 1.52 for males, and 1.36 and 1.48 for females, respectively. Correlational analyses revealed that male FES patients' cognitive impairments were specifically associated with negative symptoms, while female impairments correlated broadly with all PANSS domains. Correlational analyses revealed that in FEP patients, male cognitive impairments were specifically associated with negative symptoms, while female impairments showed broad associations with all domains of the PANSS. CONCLUSION: FES manifests as sex-divergent cognitive profiles, with males showing executive/processing speed deficits tied to negative symptoms and females exhibiting memory impairments with broader symptom associations. These findings underscore the need for sex-sensitive approaches in characterizing cognitive dysfunction in early psychosis.
引言:认知障碍是首发精神分裂症(FES)的核心特征,然而生物性别对其表现的影响仍未得到充分描述。现有证据表明慢性精神分裂症患者在认知特征上存在性别差异,但这些模式是否出现在未使用过药物的FES患者中,以及它们与临床症状的关系尚需阐明。 方法:我们招募了382名未使用过药物的FES患者和522名年龄及教育程度相匹配的健康对照者(HCs)。使用MATRICS共识认知成套测验(MCCB)评估认知功能。通过阳性和阴性症状量表(PANSS)评估临床症状。 结果:与HCs相比,FES患者表现出整体认知缺陷。按诊断组(FES和HC)分层时,通过神经心理评估量表迷宫子测验测量,男性在计划和解决问题方面的表现优于女性(<0.001),而在两组中,通过修订的简短视觉空间记忆测验评估,女性在视觉空间记忆方面表现更优(<0.001)。按性别分层时,FES患者相对于其性别匹配的HCs表现出相似的损伤严重程度模式:男性和女性FES患者在加工速度(BACS)和持续注意力(CPT)方面均表现出最明显的缺陷,男性的效应大小分别为1.64和1.52,女性为1.36和1.48。相关性分析显示,男性FES患者的认知障碍与阴性症状特异性相关,而女性障碍与PANSS所有领域广泛相关。相关性分析显示,在FEP患者中,男性认知障碍与阴性症状特异性相关,而女性障碍与PANSS所有领域广泛相关。 结论:FES表现为性别差异的认知特征,男性表现出与阴性症状相关的执行/加工速度缺陷,女性表现出与更广泛症状关联的记忆障碍。这些发现强调了在描述早期精神病认知功能障碍时采用性别敏感方法的必要性。
Cochrane Database Syst Rev. 2018-1-25
Cochrane Database Syst Rev. 2006-10-18
Psychopharmacol Bull. 2024-7-8
Schizophr Res Cogn. 2025-2-15
Biol Psychiatry. 2025-7-15
Cereb Cortex. 2024-3-1
Psychol Med. 2024-7
JAMA Netw Open. 2024-1-2